share_log

Bristol-Myers Squibb | 3: Initial statement of beneficial ownership of securities-Officer Hickey Benjamin

SEC announcement ·  Mar 5 06:58
Summary by Futu AI
Benjamin Hickey, President of RayzeBio Org., has filed an initial statement of beneficial ownership with the SEC, disclosing his stake in Bristol-Myers Squibb (BMY). The filing, dated February 26, 2024, indicates Hickey directly owns 780 shares of common stock and indirectly owns 91 shares through his spouse. Additionally, Hickey holds 30,236 restricted stock units (RSUs) that are set to vest in three equal installments starting February 1, 2025, with each RSU converting into one share of common stock upon vesting. The filing was completed on March 4, 2024, as per the requirements of Section 16(a) of the Securities Exchange Act of 1934.
Benjamin Hickey, President of RayzeBio Org., has filed an initial statement of beneficial ownership with the SEC, disclosing his stake in Bristol-Myers Squibb (BMY). The filing, dated February 26, 2024, indicates Hickey directly owns 780 shares of common stock and indirectly owns 91 shares through his spouse. Additionally, Hickey holds 30,236 restricted stock units (RSUs) that are set to vest in three equal installments starting February 1, 2025, with each RSU converting into one share of common stock upon vesting. The filing was completed on March 4, 2024, as per the requirements of Section 16(a) of the Securities Exchange Act of 1934.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.